Bing Yan is the founder of AnHeart Therapeutics. AnHeart Therapeutics has raised $100M in total funding. Latest round: Series A. Based in Hangzhou, China.
Bing Yan is the Co-Founder and President of AnHeart Therapeutics, a multinational clinical-stage biopharmaceutical company established in 2018 in New York, US. AnHeart Therapeutics focuses on the acquisition, development, and commercialization of innovative oncology drugs, including clinical-stage therapeutic cancer treatments like taletrectinib and safusidenib. The company completed a Series A funding round of approximately 100 million Chinese yuan in May 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library